ArticleDiscover oncology2026

Peripheral blood IFN-γ-producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor-based therapy.

Chengyan Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.